B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

SLC7A3

MOLECULAR TARGET

solute carrier family 7 member 3

UniProt: Q8WY07NCBI Gene: 848893 compounds

SLC7A3 (solute carrier family 7 member 3) is targeted by 3 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting SLC7A3

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Arginine0.691
2Arginine0.691
3Lysine0.691

About SLC7A3 as a Drug Target

SLC7A3 (solute carrier family 7 member 3) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 3 compounds with documented SLC7A3 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

SLC7A3 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.